Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

9th Jul 2014 11:07

RNS Number : 8541L
Sinclair IS Pharma PLC
09 July 2014
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Sinclair IS Pharma Plc

Sedol 3385674

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Update to previous filing due to change in persons subject to notification obligation

3. Full name of person(s) subject to thenotification obligation:

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4. Full name of shareholder(s) (if different from 3.):

HSBC Client Holdings Nominee (UK) Ltd

 

(Registered Shareholder)

5. Date of the transaction and date onwhich the threshold is crossed orreached:

01/07/2014

6. Date on which issuer notified:

03/07/2014

7. Threshold(s) that is/are crossed orreached:

12%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

59,987,523

59,987,523

59,987,523

12.06%

GB0033856740

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

59,987,523

12.06%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited which is the First Corporate Member of Lansdowne Partners (UK) LLP

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

 

Based on total voting rights of 497,414,773

 

This disclosure is due to a change in the persons subject to the notification. This change being the result of a corporate restructure.

 

14. Contact name:

Ruari Paton

15. Contact telephone number:

+44 020 7290 5500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXNEEKLEFF

Related Shares:

Sinclair Pharma
FTSE 100 Latest
Value8,850.63
Change-34.29